tiprankstipranks
Hyloris Pharmaceuticals SA (DE:52U)
FRANKFURT:52U
Germany Market
52U
Hyloris Pharmaceuticals SA
RESEARCH TOOLSreports
Want to see DE:52U full AI Analyst Report?

Hyloris Pharmaceuticals SA (52U) Financial Statements

7 Followers

Hyloris Pharmaceuticals SA Financial Overview

Hyloris Pharmaceuticals SA's market cap is currently €135.80M. The company's EPS TTM is €-0.103; its P/E ratio is -29.74; Hyloris Pharmaceuticals SA is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 7.21M€ 10.04M€ 2.09M€ 2.95M€ 3.10M
Gross Profit€ 5.91M€ 9.81M€ 1.99M€ 2.86M€ 2.99M
Operating Income€ -9.34M€ -7.13M€ -15.99M€ -11.64M€ -4.94M
EBITDA€ -8.42M€ -4.85M€ -14.98M€ -11.43M€ -10.78M
Net Income€ -6.33M€ -6.34M€ -15.38M€ -11.91M€ -11.58M
Balance Sheet
Cash & Short-Term Investments€ 13.78M€ 24.15M€ 30.41M€ 43.46M€ 50.54M
Total Assets€ 33.36M€ 41.34M€ 47.68M€ 61.86M€ 63.44M
Total Debt€ 1.70M€ 1.81M€ 1.75M€ 885.00K€ 12.29M
Net Debt€ -12.08M€ -21.78M€ -28.66M€ -42.57M€ -37.72M
Total Liabilities€ 6.88M€ 9.19M€ 8.61M€ 6.82M€ 15.39M
Stockholders' Equity€ 26.48M€ 32.14M€ 39.07M€ 53.91M€ 48.06M
Cash Flow
Free Cash Flow€ -6.60M€ -6.73M€ -13.11M€ -13.89M€ -12.31M
Operating Cash Flow€ -6.59M€ -6.70M€ -12.81M€ -13.15M€ -11.25M
Investing Cash Flow€ -2.52M€ 259.00K€ 9.89M€ -1.24M€ -3.08M
Financing Cash Flow€ -431.00K€ -368.00K€ -131.00K€ 7.84M€ -62.00K
Currency in EUR

Hyloris Pharmaceuticals SA Earnings and Revenue History

Income Statement >

Hyloris Pharmaceuticals SA Debt to Assets

Balance Sheet >

Hyloris Pharmaceuticals SA Cash Flow

Cash Flow >

Hyloris Pharmaceuticals SA Forecast EPS vs Actual EPS

Earnings >